The Fascinating Interplay between Growth Hormone, Insulin-Like Growth Factor-1, and Insulin
This review intends to provide the reader with a practical overview of several (patho)physiological conditions in which knowledge of the interplay between growth hormone (GH), insulin-like growth factor-1 (IGF-1), and insulin is important. This might help treating physicians in making the right decisions on how to intervene and improve metabolism for the benefit of patients, and to understand why and how metabolism responds in their specific cases. We will specifically address the interplay between GH, IGF-1, and insulin in type 1 and 2 diabetes mellitus, liver cirrhosis, and acromegaly as examples in which this knowledge is truly necessary.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
---|---|
Enthalten in: |
Endocrinology and metabolism (Seoul, Korea) - 39(2024), 1 vom: 08. Feb., Seite 83-89 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Nijenhuis-Noort, Eline C [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 01.03.2024 Date Revised 01.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.3803/EnM.2024.101 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366826999 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM366826999 | ||
003 | DE-627 | ||
005 | 20240301232315.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240114s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3803/EnM.2024.101 |2 doi | |
028 | 5 | 2 | |a pubmed24n1313.xml |
035 | |a (DE-627)NLM366826999 | ||
035 | |a (NLM)38192102 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Nijenhuis-Noort, Eline C |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Fascinating Interplay between Growth Hormone, Insulin-Like Growth Factor-1, and Insulin |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.03.2024 | ||
500 | |a Date Revised 01.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a This review intends to provide the reader with a practical overview of several (patho)physiological conditions in which knowledge of the interplay between growth hormone (GH), insulin-like growth factor-1 (IGF-1), and insulin is important. This might help treating physicians in making the right decisions on how to intervene and improve metabolism for the benefit of patients, and to understand why and how metabolism responds in their specific cases. We will specifically address the interplay between GH, IGF-1, and insulin in type 1 and 2 diabetes mellitus, liver cirrhosis, and acromegaly as examples in which this knowledge is truly necessary | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Acromegaly | |
650 | 4 | |a Diabetes mellitus, type 1 | |
650 | 4 | |a Diabetes mellitus, type 2 | |
650 | 4 | |a Growth hormone | |
650 | 4 | |a Humans | |
650 | 4 | |a Insulin | |
650 | 4 | |a Insulin-like growth factor I | |
650 | 7 | |a Growth Hormone |2 NLM | |
650 | 7 | |a 9002-72-6 |2 NLM | |
650 | 7 | |a Insulin |2 NLM | |
650 | 7 | |a Insulin-Like Growth Factor I |2 NLM | |
650 | 7 | |a 67763-96-6 |2 NLM | |
650 | 7 | |a Insulin-Like Peptides |2 NLM | |
650 | 7 | |a Human Growth Hormone |2 NLM | |
650 | 7 | |a 12629-01-5 |2 NLM | |
700 | 1 | |a Berk, Kirsten A |e verfasserin |4 aut | |
700 | 1 | |a Neggers, Sebastian J C M M |e verfasserin |4 aut | |
700 | 1 | |a Lely, Aart J van der |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Endocrinology and metabolism (Seoul, Korea) |d 2013 |g 39(2024), 1 vom: 08. Feb., Seite 83-89 |w (DE-627)NLM234220252 |x 2093-5978 |7 nnns |
773 | 1 | 8 | |g volume:39 |g year:2024 |g number:1 |g day:08 |g month:02 |g pages:83-89 |
856 | 4 | 0 | |u http://dx.doi.org/10.3803/EnM.2024.101 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 39 |j 2024 |e 1 |b 08 |c 02 |h 83-89 |